BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 21277283)

  • 1. Identification of novel small molecules that inhibit protein-protein interactions between MAGE and KAP-1.
    Bhatia N; Yang B; Xiao TZ; Peters N; Hoffmann MF; Longley BJ
    Arch Biochem Biophys; 2011 Apr; 508(2):217-21. PubMed ID: 21277283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MAGE-A, mMage-b, and MAGE-C proteins form complexes with KAP1 and suppress p53-dependent apoptosis in MAGE-positive cell lines.
    Yang B; O'Herrin SM; Wu J; Reagan-Shaw S; Ma Y; Bhat KM; Gravekamp C; Setaluri V; Peters N; Hoffmann FM; Peng H; Ivanov AV; Simpson AJ; Longley BJ
    Cancer Res; 2007 Oct; 67(20):9954-62. PubMed ID: 17942928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MAGE-C2 promotes growth and tumorigenicity of melanoma cells, phosphorylation of KAP1, and DNA damage repair.
    Bhatia N; Xiao TZ; Rosenthal KA; Siddiqui IA; Thiyagarajan S; Smart B; Meng Q; Zuleger CL; Mukhtar H; Kenney SC; Albertini MR; Jack Longley B
    J Invest Dermatol; 2013 Mar; 133(3):759-767. PubMed ID: 23096706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MAGE-RING protein complexes comprise a family of E3 ubiquitin ligases.
    Doyle JM; Gao J; Wang J; Yang M; Potts PR
    Mol Cell; 2010 Sep; 39(6):963-74. PubMed ID: 20864041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reconstitution of the KRAB-KAP-1 repressor complex: a model system for defining the molecular anatomy of RING-B box-coiled-coil domain-mediated protein-protein interactions.
    Peng H; Begg GE; Schultz DC; Friedman JR; Jensen DE; Speicher DW; Rauscher FJ
    J Mol Biol; 2000 Feb; 295(5):1139-62. PubMed ID: 10653693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MAGE-A tumor antigens target p53 transactivation function through histone deacetylase recruitment and confer resistance to chemotherapeutic agents.
    Monte M; Simonatto M; Peche LY; Bublik DR; Gobessi S; Pierotti MA; Rodolfo M; Schneider C
    Proc Natl Acad Sci U S A; 2006 Jul; 103(30):11160-5. PubMed ID: 16847267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-34a confers chemosensitivity through modulation of MAGE-A and p53 in medulloblastoma.
    Weeraratne SD; Amani V; Neiss A; Teider N; Scott DK; Pomeroy SL; Cho YJ
    Neuro Oncol; 2011 Feb; 13(2):165-75. PubMed ID: 21177782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kruppel-associated box domain-associated protein-1 as a latency regulator for Kaposi's sarcoma-associated herpesvirus and its modulation by the viral protein kinase.
    Chang PC; Fitzgerald LD; Van Geelen A; Izumiya Y; Ellison TJ; Wang DH; Ann DK; Luciw PA; Kung HJ
    Cancer Res; 2009 Jul; 69(14):5681-9. PubMed ID: 19584288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melanoma associated antigen (MAGE)-A3 promotes cell proliferation and chemotherapeutic drug resistance in gastric cancer.
    Xie C; Subhash VV; Datta A; Liem N; Tan SH; Yeo MS; Tan WL; Koh V; Yan FL; Wong FY; Wong WK; So J; Tan IB; Padmanabhan N; Yap CT; Tan P; Goh LK; Yong WP
    Cell Oncol (Dordr); 2016 Apr; 39(2):175-86. PubMed ID: 26868260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Select cancer testes antigens of the MAGE-A, -B, and -C families are expressed in mast cell lines and promote cell viability in vitro and in vivo.
    Yang B; O'Herrin S; Wu J; Reagan-Shaw S; Ma Y; Nihal M; Longley BJ
    J Invest Dermatol; 2007 Feb; 127(2):267-75. PubMed ID: 16960553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular determinants for targeting heterochromatin protein 1-mediated gene silencing: direct chromoshadow domain-KAP-1 corepressor interaction is essential.
    Lechner MS; Begg GE; Speicher DW; Rauscher FJ
    Mol Cell Biol; 2000 Sep; 20(17):6449-65. PubMed ID: 10938122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic control of MAGE gene expression by the KIT tyrosine kinase.
    Yang B; Wu J; Maddodi N; Ma Y; Setaluri V; Longley BJ
    J Invest Dermatol; 2007 Sep; 127(9):2123-8. PubMed ID: 17495964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [KAP-1, a scaffold protein in transcription regulation].
    Yang D; Jiang Y; He FC
    Yi Chuan; 2007 Feb; 29(2):131-6. PubMed ID: 17369165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two novel Krüppel-associated box-containing zinc-finger proteins, KRAZ1 and KRAZ2, repress transcription through functional interaction with the corepressor KAP-1 (TIF1beta/KRIP-1).
    Agata Y; Matsuda E; Shimizu A
    J Biol Chem; 1999 Jun; 274(23):16412-22. PubMed ID: 10347202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hetero-oligomerization among the TIF family of RBCC/TRIM domain-containing nuclear cofactors: a potential mechanism for regulating the switch between coactivation and corepression.
    Peng H; Feldman I; Rauscher FJ
    J Mol Biol; 2002 Jul; 320(3):629-44. PubMed ID: 12096914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The melanoma-associated antigen MAGE-D2 suppresses TRAIL receptor 2 and protects against TRAIL-induced apoptosis in human melanoma cells.
    Tseng HY; Chen LH; Ye Y; Tay KH; Jiang CC; Guo ST; Jin L; Hersey P; Zhang XD
    Carcinogenesis; 2012 Oct; 33(10):1871-81. PubMed ID: 22791814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The structurally disordered KRAB repression domain is incorporated into a protease resistant core upon binding to KAP-1-RBCC domain.
    Peng H; Gibson LC; Capili AD; Borden KL; Osborne MJ; Harper SL; Speicher DW; Zhao K; Marmorstein R; Rock TA; Rauscher FJ
    J Mol Biol; 2007 Jul; 370(2):269-89. PubMed ID: 17512541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer-testis antigen MAGE-C2 binds Rbx1 and inhibits ubiquitin ligase-mediated turnover of cyclin E.
    Hao J; Song X; Wang J; Guo C; Li Y; Li B; Zhang Y; Yin Y
    Oncotarget; 2015 Dec; 6(39):42028-39. PubMed ID: 26540345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation.
    De Smet C; De Backer O; Faraoni I; Lurquin C; Brasseur F; Boon T
    Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7149-53. PubMed ID: 8692960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the MAGE-1 tumor antigen is up-regulated by the demethylating agent 5-aza-2'-deoxycytidine.
    Weber J; Salgaller M; Samid D; Johnson B; Herlyn M; Lassam N; Treisman J; Rosenberg SA
    Cancer Res; 1994 Apr; 54(7):1766-71. PubMed ID: 7511051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.